On May 23, the General Office of the Beijing Municipal people's Government issued the Beijing Action Plan for accelerating Synergetic Innovation in Medicine and Health (2024-2026) (referred to as the Action Plan).
The Action Plan makes it clear that by 2026, the total size of the pharmaceutical and health industry will reach 1.Rtgcasino.25 trillion yuan (of which the operating income of the pharmaceutical industry reached 240 billion yuan), and the annual investment in fixed assets was more than 10 billion yuan. To achieve 5-8 scientific discoveries and technological breakthroughs leading the world, 10 new innovative drugs and 30 innovative medical devices (002173) have been approved, and 1-2 research hospitals have been built. Introduction and training of more than 10, 000 multi-level professionals; municipal medical and health industry investment fund leveraged social venture capital of 20 billion yuan per year; 10 high-quality characteristic parks. The industrial carrying capacity has been further enhanced, and the formation of modern pharmaceutical and health industrial clusters with global influence has been accelerated.
On the whole, the Action Plan puts forward by focusing on eight major aspects.Rtgcasino34 key tasks.
Among them, in terms of strengthening the source of innovation and speeding up the transformation of cutting-edge technological achievements, it is proposed to accelerate the output of major achievements in the field of life science, and deploy "nuclear explosion points" in cutting-edge technological fields such as cell gene therapy, brain-computer interface, and synthetic biology. to give birth to subversive and leading scientific discoveries and technological breakthroughs.
In terms of strengthening clinical research and strengthening the coordination between medical research and industry, the Action Plan requires to optimize the process for clinical institutions to start clinical trial projects and reduce the start-up time of clinical trials to less than 25 weeks.
In the aspect of stimulating the value of data elements and promoting digital empowerment, speed up the development of artificial intelligence technology empowerment industry represented by medical model. Support the development and application of large medical models, promote the research and application of products such as digital therapy and artificial intelligence auxiliary therapy, and promote the research and development of new drugs for artificial intelligence technology.
In the creation of a full-process service system, speed up the research and development to the application process, accelerate the innovation of pharmaceutical equipment in hospital application. To promote the establishment of a long-term mechanism for medical institutions to hold regular working meetings of the Committee on Pharmacy Administration and Pharmacology. We will strengthen the work related to the entry of service innovative drugs into the national medical insurance drug catalogue. Guide municipal hospitals to speed up the admission and application of innovative drugs, and the drugs included in the medical insurance catalogue should be admitted to hospital as soon as possible in accordance with the principle of "should be fully dispensed".
In terms of optimizing the variety structure and promoting the energy level of the industry, the Action Plan proposes to promote the innovation and development of drugs. We will promote the research and development and application of the next generation of double polyclonal antibodies, infectious disease vaccines and other major varieties, support the international registration and export of drugs, improve the quality of generic drugs, and produce 30 varieties worth 1 billion yuan. Varieties with great market potential, such as supporting cell therapy and genetic drugs, have rapidly formed industrial increments. Promote the research and development of important drugs with new targets and mechanisms in the fields of inflammation, infection and so on.
In the classified and precise implementation of policies to help the echelon development of enterprises, the Action Plan makes it clear that it is necessary to vigorously gather leading enterprises. Attract 3-5 multinational enterprises to Beijing for development. Support multinational enterprises in Beijing to upgrade their industrial energy levels, expand the scale of R & D centers, and introduce leading technologies and varieties. Give full play to the influence of top scientists and well-known doctors, play the role of platforms such as research wards, and attract no less than 5 leading enterprises to develop on the ground. To expand and strengthen the backbone enterprises with high growth. Support enterprises to set up overseas R & D centers, innovation funds, and carry out global investment and mergers and acquisitions. We will support the accelerated development of enterprises with a revenue scale of 1 billion-2 billion yuan, and strive to have 15 enterprises with a revenue scale of more than 5 billion yuan within three years. Improve the economies of scale of the third-party service platform. Introduce no less than 5 high-quality pharmaceutical outsourcing service platforms at home and abroad, lay out key service platforms such as international registration and sales, and cultivate characteristic technical platforms such as carrier delivery and disease model animals. Introduce no less than 3 internationally renowned professional incubators and accelerators. Establish a service channel for the listing of enterprises and create a good environment for landing on the Beijing Stock Exchange. We will support enterprises to log on to domestic and foreign capital markets and add 20 new listed enterprises.
In terms of highlighting regional advantages and building a linkage development pattern of industrial agglomeration, the Action Plan clearly plans to add not less than 3000 mu of industrial land available for industrial use, promote the construction of a standard factory building of 1.2 million square meters, and start a new standard factory building of 1.8 million square meters. Promote Haidian District to build a new benchmark for the integration of intelligence and medicine. Speed up the construction of Zhongguancun (000931) Science City International Medical Valley and Zhongguancun Comprehensive Free Trade Zone, and build characteristic parks in Shangzhuang, Xisanqi and other places. Promote Changping District to create a new engine for innovation and speed up. We will promote the construction of new highlands for advanced manufacturing in Daxing District, speed up the north-south expansion of Daxing Biopharmaceutical Industrial Base, and lay out characteristic parks such as nucleic acid drugs and high-end medical devices. We will promote the construction of Beijing Economic and technological Development Zone and create new landmarks of medicine and equipment.
